Yoshifumi Uwamino

This study evaluates the neutralizing antibody response induced by XEC-based monovalent vaccines against multiple SARS-CoV-2 variants, showing enhanced immunity against JN.1 subvariants compared to other variants.

This study evaluates the humoral immune response induced by LP.8.1-based vaccines against multiple SARS-CoV-2 variants, showing effective cross-neutralization and immune boosting.

This study compares the antiviral humoral immunity induced by two JN.1 monovalent mRNA vaccines against multiple SARS-CoV-2 Omicron subvariants and XEC, showing both vaccines boost immunity with statistical significance.

This study analyzes the virological characteristics of the SARS-CoV-2 XEC variant, showing it has higher infectivity and immune evasion compared to KP.3.1.1, contributing to its higher reproductive number and potential dominance.

This study investigates the virological properties of the SARS-CoV-2 KP.2 variant, finding it has higher viral fitness and immune resistance compared to JN.1, contributing to its rapid spread.

The paper assesses the humoral immune response to XBB.1.5 vaccine in infection-naive and XBB-infected individuals against various SARS-CoV-2 variants.

The paper reports a genome-wide association study of COVID-19 in a Japanese population, identifying a novel risk variant associated with severe disease in younger patients.